RA PHARMACEUTICALS INC
CUSIP 74933V108
Ra Pharmaceuticals Inc has 97 institutional holders in Filings Flow’s 13F database, together reporting 26.13M shares worth $8.1B as of Q3 2019. The largest reported holders are Hbk Investments L P, Norges Bank, and Daiwa Securities Group Inc..
Institutional Holders
97
Q3 2019
Reported Value
$8.1B
Ticker
unmapped
private placement or foreign
Quarters Tracked
4
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| HBK INVESTMENTS L P$9.9B AUM | 0.51% | $96M | 2.00M | Q1 2021 |
| Daiwa Securities Group Inc.$34.8B AUM | 0.00% | $32,000 | 266 | Q2 2020OLDER |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.